Search

Your search keyword '"Marions, L."' showing total 162 results

Search Constraints

Start Over You searched for: Author "Marions, L." Remove constraint Author: "Marions, L."
162 results on '"Marions, L."'

Search Results

51. Knowledge of cervical cancer and HPV vaccine in Bangladeshi women: a population based, cross-sectional study.

52. Reproductive and Lifestyle Factors Associated with Endometriosis in a Large Cross-Sectional Population Sample.

53. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial.

55. Validity of self-reported endometriosis and endometriosis-related questions in a Swedish female twin cohort.

57. Sexual and testing behaviour associated with Chlamydia trachomatis infection: a cohort study in an STI clinic in Sweden.

58. Gonorrhoea Diagnostic and Treatment Uncertainties: Risk Factors for Culture Negative Confirmation after Positive Nucleic Acid Amplification Tests.

60. The impact of maternal factors on mortality rates among children under the age of five years in a rural Ugandan population between 2002 and 2012.

61. Follow-up on oral and cervical human papillomavirus prevalence 2013-2015 in youth at a youth clinic in Stockholm, Sweden.

62. Adverse pregnancy outcomes in rural Uganda (1996-2013): trends and associated factors from serial cross sectional surveys.

64. Maternal emotional wellbeing over time and attachment to the fetus when a malformation is detected.

65. Heritability of endometriosis.

67. The efficacy, safety and acceptability of medical termination of pregnancy provided by standard care by doctors or by nurse-midwives: a randomised controlled equivalence trial.

68. Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination.

69. Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study.

70. Understanding the barriers and myths limiting the use of intrauterine contraception in nulliparous women: results of a survey of European/Canadian healthcare providers.

71. Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey.

72. Pregnancy termination due to fetal anomaly: women's reactions, satisfaction and experiences of care.

73. Current clinical features of complete and partial hydatidiform mole in Sweden.

74. Effect of post-menstrual regulation family-planning service quality on subsequent contraceptive use in Bangladesh.

76. Pregnant women's perspectives on decision-making when a fetal malformation is detected by ultrasound examination.

77. Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types.

79. Pregnant women's experiences, needs, and preferences regarding information about malformations detected by ultrasound scan.

81. Choriocarcinoma following ovarian hydatidiform mole: a case report.

82. Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos.

83. Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden.

84. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden.

85. Women's perception of cervical cancer and its prevention in rural Laos.

87. [Chlamydia a common cause of miction problems].

89. Effect of a peer-educational intervention on provider knowledge and reported performance in family planning services: a cluster randomized trial.

90. Occurrence of pharyngeal Chlamydia trachomatis is uncommon in patients with a suspected or confirmed genital infection.

91. Barriers to high-quality primary reproductive health services in an urban area of Iran: views of public health providers.

92. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.

93. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.

94. A randomised controlled trial of intravaginal dinoprostone, intravaginal misoprostol and transcervical balloon catheter for labour induction.

95. Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination.

96. The incidence of obstetric anal sphincter rupture in primiparous women: a comparison between two European delivery settings.

97. Quality of family planning services at primary care facilities in an urban area of East Azerbaijan, Iran.

98. Health providers' competence in the management of reproductive tract infections in Vientiane, Lao People's Democratic Republic.

99. [No increase of ectopic pregnancies among adolescents].

100. Mifepristone dose in the regimen with misoprostol for medical abortion.

Catalog

Books, media, physical & digital resources